Industry news · Business & finance← The news desk

✦ The Dispatch

Demant goes on offensive with US veterans: “We aim to steadily expand our position”

A dispatch from MedWatch — filed

Low-angle view of a large government building with an American flag draped on its facade; a blue canopy reading "Department of Veterans Affairs" in the foreground.
✦ PlateLow-angle view of a large government building with an American flag draped on its facade; a blue canopy reading "Department of Veterans Affairs" in the foreground.

After six months of market share gains, CEO Søren Nielsen sees the VA as one of Demant’s biggest growth opportunities, but acknowledges that Sonova is still ahead.

Continue reading at MedWatch

✦ The floor

Discussion

Signed responses from readers of the wire.

✦ Clinical Takeaway ✦

No actionable change — this is a corporate market-strategy announcement with no implications for clinical practice.

✦ Why It Matters ✦

Competition between major manufacturers for the VA contract shapes which hearing aids are most accessible to the large and high-need veteran population, potentially influencing device availability and pricing across the sector.

✦ Key Points ✦
  1. 01Demant CEO Søren Nielsen publicly targets the U.S. VA hearing-aid market as a priority growth area.
  2. 02Demant reports market share gains in the VA channel over the past six months.
  3. 03Sonova is acknowledged as the current market leader in VA hearing-aid supply.
  4. 04The VA represents one of the largest single institutional buyers of hearing aids in the world.
  5. 05Increased manufacturer competition in the VA channel could affect device selection and contract pricing.
✦ Claims & Evidence ✦

Demant has gained market share in the U.S. VA hearing-aid market over the past six months.

quoteunclear

Sonova currently holds a leading position in the U.S. VA hearing-aid market.

quotepartially supported
✦ Related stories ✦